Korro Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Korro Bio, Inc. (KRRO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents55.64166.1536.3383.49220.34217.36
Short-Term Investments70.450.0018.9235.040.000.00
Cash & Short-Term Investments126.10166.1555.25118.53220.34217.36
Accounts Receivable1.700.000.000.000.000.00
Inventory0.000.000.000.000.000.00
Other Current Assets3.743.021.231.240.100.20
Total Current Assets131.53172.7357.08119.78225.06221.36
Non-Current Assets
Property, Plant & Equipment (Net)51.5542.8211.897.1437.842.96
Long-Term Investments36.960.000.000.000.000.00
Other Non-Current Assets6.206.124.770.661.820.10
Total Non-Current Assets94.7148.9416.667.8039.663.06
Total Assets226.24221.6673.74127.58264.72224.42
Current Liabilities
Accounts Payable3.997.282.610.7912.174.46
Short-Term Debt1.280.000.000.000.000.00
Accrued Liabilities2.121.470.340.440.000.00
Deferred Revenue3.510.000.000.000.000.00
Other Current Liabilities0.280.840.210.505.060.17
Total Current Liabilities14.9619.488.704.9526.6352.78
Non-Current Liabilities
Long-Term Debt43.4831.220.2143.0245.600.18
Other Non-Current Liabilities1.471.050.090.000.000.00
Total Non-Current Liabilities50.8732.27164.07164.8345.603.08
Total Liabilities65.8351.75172.77169.7872.2355.86
Stockholders' Equity
Common Stock0.010.010.000.010.000.00
Retained Earnings-266.59-183.01-101.83-43.80-95.37-68.89
Accumulated Other Comprehensive Income0.270.000.00-0.010.000.05
Additional Paid-in Capital426.72352.912.811.60287.83236.16
Shares Outstanding9.388.028.008.000.000.00
Total Stockholders' Equity160.42169.91-99.03-42.21192.49167.36
Total Liabilities & Equity226.24221.6673.74127.58264.72224.42